Merger talk was in the air Tuesday, on word that Endonovo Therapeutics, Inc. (OTC:ENDV) had thrown in its lot with privately-held Veterans Healthcare Supply Solutions Inc. (VHSS), on a long-term agreement encompassing the distribution of SofPulse® to Veterans Administration Facilities and Department of Defense Healthcare Facilities.
Endonovo CEO Alan Collier said, "The team at VHSS have streamlined and improved the sales, marketing and distribution of medical devices to VA and DoD facilities.
"VHSS is a true leader in the space and we are thrilled to have the capacity to support their mission. This agreement, which includes direct delivery to all medical facilities, extends beyond traditional distribution and includes access to their 900 Federal Contract Officers as well as their distribution center with a state of the art ERP and WMS Systems."
Los Angeles-based Endonovo is a commercial-stage developer of non-invasive wearable Electroceuticals™ therapeutic devices.
Its shares rocketed 18-100ths of a cent, or 17.7%, to 1.2 cents approaching noon ET Tuesday, on a volume of 1.4 million shares.
